Grzegorz Kaszyński

CEO of Sygnis Bio Technologies

Grzegorz Kaszyński

CEO of Sygnis Bio Technologies

Biography

Chief Executive Officer of Sygnis Bio Technologies. He has more than 12 years’ experience in scientific equipment market, with strong focus on high resolution live cell imaging and tissue engineering techniques. Sygnis Bio Technologies is a distributor of 3D bioprinting market leader, CELLINK, for Eastern Europe. Bioprinting 3d solutions partner for “Bionic Pancreas” of FBiRN. One of the few specialist in the field of 3D holotomographic imaging.

Sygnis Bio Technologies expertise:

  • Nanolive cell 3D super-resolution imaging
  • PALM/dSTORM/SIM super-resolution tabletop microscopy
  • Extrusion based, single cell, DLP and holographic 3D bioprinting
  • Micropatterning and biopatterning

All session by Grzegorz Kaszyński